IDEAYA Biosciences (IDYA)
(Delayed Data from NSDQ)
$41.00 USD
+0.68 (1.69%)
Updated May 21, 2024 04:00 PM ET
After-Market: $40.85 -0.15 (-0.37%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Earnings News For IDYA
-
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q3 Loss, Lags Revenue Estimates
-
IDEAYA Biosciences, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Lags Revenue Estimates
-
IDEAYA Biosciences, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Should You Buy?
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Q3 Earnings and Revenues Beat Estimates
-
IDEAYA Biosciences, Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Should You Buy?
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Tops Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Misses Revenue Estimates
-
Earnings Preview: IDEAYA Biosciences, Inc. (IDYA) Q3 Earnings Expected to Decline
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Lags Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Misses Revenue Estimates